Trade Insider
by Emma Mitchell on September 6, 2022

Top 5 Covid-19 Stocks That Are Good To Buy Right Now

It has become possible for investors to direct their funds toward Covid-19 stocks as soon as vaccines emerge in the world. They are now widely available in all parts of the world including the U.S., Canada, and Europe. Despite the fact that at first the majority of people were skeptical about vaccines and a lot of controversial opinions appeared, governments made sure to entice people to get vaccinated since it was pretty much the one and only solution to the pandemic. So, the vaccine manufacturers have gained immense popularity due to this exact reason and several drugmakers have already won regulatory approvals in order to sell the stocks.

However, before investing in Covid-19 stocks, you have to take into account several factors. For starters, it is recommended to figure out the status of the company’s vaccine and make sure that they have a full right and regulation to sell their assets. Also, it is crucial to get information about every problem vaccine manufacturers have encountered in this process since even regulated companies have some issues when it comes to commercial business. Lastly, we would recommend investors check other products of the vaccine makers as well in order to see whether they have succeeded in selling them or not. By doing so, you will be assured of the safety and reliability of these companies! Down below, we are going to point out the top 5 Covid-19 stocks that are good to buy at the moment!


Pfizer started manufacturing the Covid-19 vaccine in 2020 when it partnered with one of the leading biotechnology companies called BioNTech. This decision was apparently tremendous since the vaccine was the first to win a U.S. EUA and earned the name of the largest commercial success of the year. However, we have to mention that the shares of the smaller vaccine manufacturers have drawn relatively higher numbers compared to this pharmaceutical company’s stocks. This is because of the huge size of Pfizer since it is very difficult to stick out one product here that will experience an enormous alteration in the stock price. What’s more, the company has lost major patents for several products over the last few years and experienced some issues in regard to clinical setbacks for them. Despite the aforementioned facts, we want to highlight that it is still greatly beneficial to purchase their stocks since experts state that Pfizer will deliver solid price growth at least for the next five years!


As we have noted above, BioNTech is a partner of Pfizer so it is getting benefits from Pfizer’s financial resources, regulatory expertise, and global manufacturing capacity. The company’s contribution to the Covid-19 vaccine manufacturing was tremendous due to its messenger RNA (mRNA) technology. As long as, vaccine booster doses are increased in the world, BioNTech’s fortunes will follow its path as well in the upcoming years. What’s more, this company operates in other fields as well besides Covid-19 vaccines, and one of their prominent product is an experimental mRNA therapy in order to cure solid tumors such as Melanoma and several others. So, the advantages of buying BioNTech stocks are pretty clear at this point!


When it comes to Moderna, we have to note that it has quickly gained popularity after the above-mentioned companies, and received a U.S. EUA for its COVID-19 vaccine. However, the important factor here is that Moderna will most probably earn much more money compared to Pfizer and BioNTech since it does not share profits with other companies. Moderna will continue to grow until the demand for Covid-19 vaccines is high and given the fact that new variants of this virus have already appeared, the demand will most likely retain its level. Lastly, the company will most likely expand its pipeline in the upcoming months, so you don’t have to worry about anything when purchasing its stocks.

Johnson & Johnson

Johnson & Johnson has hit third place when it comes to securing U.S. authorization for producing the Covid-19 vaccine. Its product only requires a single dose in order to take full effect and the good news is that the company is selling this vaccine at cost without getting profits for now. What’s more, they have manufactured far fewer doses of vaccine compared to the above-mentioned companies due to several factors but mainly because of a lower overall efficacy. Johnson & Johnson stock is considered one of the safest options in the entire market given its immense size and diverse operations in terms of healthcare.


Last but not least company on our list is called AstraZeneca. At first, it was widely expected that this company would win the COVID-19 vaccine race since it made the biggest deal with the U.S. government at the time in order to supply nearly 300 million doses. However, this vaccine still is not available in the USA, and what’s more, AstraZeneca faced some difficulties with European Union as well due to failing to fulfill its supply commitments before reaching a settlement in September 2021. However, it is still beneficial to buy AstraZeneca’s stocks right now since its drug pipeline is well-developed and features various products with strong sales growth.

By Emma Mitchell

More content by Emma Mitchell

Comments (0 comment(s))

Copyright 2022